L-Tartaric acid → HCID 86756842, compound
Reaction equation
[O:1]=[S:2]1(=[O:16])[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[CH:6]=[C:5]([C:13]([NH2:15])=[O:14])[CH2:4][CH2:3]1.[C:17]([OH:26])(=[O:25])[C@@H:18]([C@H:20]([C:22]([OH:24])=[O:23])[OH:21])[OH:19]>C1COCC1>[C:17]([OH:26])(=[O:25])[C@@H:18]([C@H:20]([C:22]([OH:24])=[O:23])[OH:21])[OH:19].[O:1]=[S:2]1(=[O:16])[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[CH:6]=[C:5]([C:13]([NH2:15])=[O:14])[CH2:4][CH2:3]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
In THF (30 ml) was dissolved N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]phenyl]-7-[4-(2-propoxyethoxy)phenyl)]-1,1-dioxo-2,3-dihydro-1-benzothiepine-4-carboxamide (1.0 g). To the solution was added L-tartaric acid (0.36 mg), and the mixture was stirred at room temperature for 12 hours. Under reduced pressure, the solvent was removed, and the residue was recrystallized from ethanol to give N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]phenyl]-7-[4-(2-propoxyethoxy)phenyl)]-1,1-dioxo-2,3-dihydro-1-benzothiepine-4-carboxamide L-tartarate (Compound 134) (1.7 g).
Workup
- customUnder reduced pressure, the solvent was removed
- customthe residue was recrystallized from ethanol
Sources & evidence
- ORD record
- ord-2252bb4e36994bc09e7a203a4e0267de
- Source dataset
- uspto-grants-2001_05
- Patent number
- US06235771B1
Reaction notes
Loading…